香港電訊-SS(06823.HK):2024年EBITDA增加3%至達到137.43億港元
格隆匯2月20日丨香港電訊-SS(06823.HK)發佈公吿,截至2024年12月31日止年度,總收益增加1%至港幣347.53億元;總收益(未計流動通訊產品銷售)增加2%至港幣320.31億元;集團推行各種人工智能應用部署等措施提升效益,帶動EBITDA總計增加3%至港幣137.43億元;經調整資金流亦增加3%至港幣59.73億元;股份合訂單位持有人應占溢利增加2%至港幣50.70億元;每個股份合訂單位基本盈利為港幣66.92分;及每個股份合訂單位的末期分派為港幣45.88分,因此全年總分派為港幣78.80分,相當於全數分派本年度每個股份合訂單位的經調整資金流。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.